Leveraging Synergistic Solubility in the Development of a Direct Isolation Process for Nemtabrutinib

Yonggang Chen(Merck & Co., Inc., Rahway, NJ, USA (United States)), E. B. Sirota(Merck & Co., Inc., Rahway, NJ, USA (United States)), Alison C. McQuilken(Merck & Co., Inc., Rahway, NJ, USA (United States)), Luca Iuzzolino(Merck & Co., Inc., Rahway, NJ, USA (United States)), Clara Hartmanshenn(Merck & Co., Inc., Rahway, NJ, USA (United States)), James Corry(Merck & Co., Inc., Rahway, NJ, USA (United States)), Samantha A. Burgess(Pacific Northwest National Laboratory), Richard Desmond(Merck & Co., Inc., Rahway, NJ, USA (United States)), Justin A. Newman(Merck & Co., Inc., Rahway, NJ, USA (United States)), Morgan Crawford(Merck & Co., Inc., Rahway, NJ, USA (United States)), Hanlin Luo(Merck & Co., Inc., Rahway, NJ, USA (United States)), Hong Ren(Merck & Co., Inc., Rahway, NJ, USA (United States)), Nadine Kuhl(Merck & Co., Inc., Rahway, NJ, USA (United States)), David A. Thaisrivongs(MACOM (United States)), Zhu Liu(Huazhong Agricultural University), Cheol K. Chung(Merck & Co., Inc., Rahway, NJ, USA (United States)), Zhixun Wang(Zhongshan Hospital), Erik D. Guetschow(MACOM (United States))
Organic Process Research & Development
March 10, 2023
Cited by 8


Related Papers